Favourable long-term outcome after matched sibling transplantation for fanconi-anemia (FA) and in vivo T-cell depletion

Klinische Padiatrie

Volumn 220, Issue 3, 2008, Pages 147-152

  Huck, K ^a   Hanenberg, H ^b   Nurnberger W ^a,c   Dilloo, D ^a   Burdach, S ^a,d   Gobel U ^a   Laws, H J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Klinik fur Knochenmarktransplantation und Hamatologie/Onkologie GmbH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

CD25 monoclonal antibody; Fanconi anemia; GvHD; Secondary malignancies; Stem cell transplantation

Indexed keywords

BASILIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; OXYMETHOLONE; THYMOCYTE ANTIBODY;

ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENGRAFTMENT; EXPERIENCE; FANCONI ANEMIA; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HYPERTENSION; IRRADIATION; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; SIBLING; T CELL DEPLETION; THERAPY EFFECT; THORAX; UNSPECIFIED SIDE EFFECT;

BONE MARROW PURGING; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FANCONI ANEMIA; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHATIC IRRADIATION; LYMPHOCYTE DEPLETION; MALE; T-LYMPHOCYTES; TRANSPLANTATION, ISOGENEIC;

EID: 44449163396     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1065326     Document Type: Article

References (59)

1. Aker M, Varadi G, Slavin S, Nagler A. Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hematol Oncol 1999; 21: 237-239
2. Alter BP, Greene MH, Velazquez I, Rosenberg PS. Cancer in Fanconi anemia. Blood 2003; 101: 2072
3. Andreassen PR, D'Andrea AD, Taniguchi T. ATR couples FANCD2 mono-ubiquitination to the DNA-damage response. Genes Dev 2004; 18: 1958-1963
4. Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis In: Dracopoli NC, Haines JL, Korf BR, et al (Eds). Current Protocols in Human Genetics. New York: Current Protocols 1994; 8.7: 1-12
5. Auerbach AD, Buchwald M, Joenje H. Fanconi anemia In: Vogelstein B, Kinzler KW (Eds), The Genetic Bases of Human Cancer 2nd Edition. New York: McGraw-Hill, Inc. 2002; 289-306
6. Boulad F, Gillio A, Small TN, George D, Prasad V, Torok-Castanza J, Regan AD, Collins N, Auerbach AD, Kernan NA. O'Reilly RJ. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 2000; 111: 1153-1157
7. Brenner MK, Wulf GG, Rill DR, Luo KL, Goodell MA, Mei Z, Kuehnle I, Brown MP, Pule M, Heslop HE, Krance RA. Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man. Ann N Y Acad Sci 2003; 996: 80-88
8. Cahn JY, Bordigoni P, Tiberghien P, Milpied N, Brion A, Widjenes J, Lioure B, Michel G, Burdach S, Kolb HJ et al. Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study. Transplantation 1995; 60: 939-942
9. Calaminus G, Weinspach S, Teske C, Göbel U. Quality of survival in children and adolescents after treatment for childhood cancer: the influence of reported late effects on health related quality of life. Klin Padiatr 2007; 219: 152-157
10. Chan KW, Li CK, Worth LL, Chik KW, Jeha S, Shing MK, Yuen PM. A fludarabine-based conditioning regimen for severe aplastic anemia. Bone Marrow Transplant 2001; 27: 125-128
11. Chaudhury S, Auerbach AD, Kernan NA, Small TN, Prockop SE, Scaradavou A, Heller G, Wolden S, O'Reilly RJ, Boulad F. Fludarabine-based cytoreductive regimen and T-cell depleted grafts from alternative donors for the treatment of high risk patients with Fanconi anemia. Br J Haematol 2008; 140: 644-655
12. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni Jr JF, Boice Jr JD. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897-904
13. Davies SM, Khan S, Wagner JE, Arthur DC, Auerbach AD, Ramsay NK, Weisdorf DJ. Unrelated donor bone marrow transplantation for Fanconi anemia. Bone Marrow Transplant 1996; 17: 43-47
14. Medeiros CR de, Silva LM, Pasquini R. Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning. Bone Marrow Transplant 2001; 28: 110-112
15. Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386-392
16. Dorsman JC, Levitus M, Rockx D, Rooimans MA, Oostra AB, Haitjema A, Bakker ST, Steltenpool J, Schuler D, Mohan S, Schindler D, Arwert F, Pals G, Mathew CG, Waisfisz Q, Winter JP de, Joenje H. Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol 2007; 29: 211-218
17. Dufour C, Rondelli R, Locatelli F, Miano M, Di Girolamo G, Bacigalupo A, Messina C, Porta F, Balduzzi A, Iorio AP, Buket E, Madon E, Pession A, Dini G, Di Bartolomeo P. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO. Br J Haematol 2001; 112: 796-805
18. Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, Altay C, Poole J, Stones D, Kwee ML, Weel-Sipman M van, Havenga C, Morgan N, Winter J de, Digweed M, Savoia A, Pronk J, Ravel T de, Jansen S, Joenje H, Gluckman E, Mathew CG. Association of complementation group and mutation type with clinical outcome in fanconi anemia. Blood 2000; 96: 4064-4070
19. Farzin A, Davies SM, Smith FO, Filipovich A, Hansen M, Auerbach AD, Harris RE. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience. Br J Haematol 2007; 136: 633-640
20. Gluckman E, Auerbach AD, Horowitz MM, Sobotinski KA, Ash RC, Bortin MM, Butturini A, Camitta BM, Champlin RE, Friedrich W, Good RA, Gordon-Smith EC, Harris RE, Klein JP, Ortega JJ, Pasquini R, Ramsay NKC, Speck B, Vowels MR, Zhang M-J, Gale RP. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86: 2856-2862
21. Gluckman E, Devergie A, Benbunan A, Bridier A, Dutreix J. Bone marrow transplantation in severe aplastic anemia using cyclophosphamide and thoracoabdominal irradiation. Prog Clin Biol Res 1984; 148: 325-333
22. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431-440
23. Gluckman E, Devergie A, Schaison G, Bussel A, Berger R, Sohier J, Bernard J. Bone marrow transplantation in Fanconi anaemia. Br J Haematol 1980; 45: 557-564
24. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J, Kurtzberg J, Champagne MA, Bonfim C, Bittencourt M, Darbyshire P, Fernandez MN, Locatelli F, Pasquini R. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073-1082
25. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304
26. Gross M, Hanenberg H, Lobitz S, Friedl R, Herterich S, Dietrich R, Gruhn B, Schindler D, Hoehn H. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction. Cytogenet Genome Res 2002; 98: 126-135
27. Guardiola P, Pasquini R, Dokal I, Ortega JJ, Weel-Sipman M van, Marsh JC, Ball SE, Locatelli F, Vermylen C, Skinner R, Ljungman P, Miniero R, Shaw PJ, Souillet G, Michallet M, Bekassy AN, Krivan G, Di Bartolomeo P, Heilmann C, Zanesco L, Cahn JY, Arcese W, Bacigalupo A, Gluckman E. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000; 95: 422-429
28. Guardiola P, Socie G, Li X, Ribaud P, Devergie A, Esperou H, Richard P, Traineau R, Janin A, Gluckman E. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA identical sibling donors: risk factors and influence on outcome. Blood 2004; 103: 73-77
29. Hanenberg H, Batish SD, Pollok KE, Vieten L, Verlander PC, Leurs C, Cooper RJ, Göttsche K, Haneline L, Clapp DW, Lobitz S, Williams DA, Auerbach AD. Phenotypic correction of primary Fanconi anemia T cells from patients with retroviral vectors as a diagnostic tool. Exp Hematol 2002; 30: 410-420
30. Ho VT, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192-3204
31. Houghtaling S, Granville L, Akkari Y, Torimaru Y, Olson S, Finegold M, Grompe M. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice. Cancer Res 2005; 65: 85-91
32. Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, Meyn MS, Grompe M. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev 2003
33. Huck K, Hanenberg H, Gudowius S, Fenk R, Kalb R, Neveling K, Betz B, Niederacher D, Haas R, Göbel U, Kobbe G, Schindler D. Delayed diagnosis and complications of Fanconi anaemia at advanced age - a paradigm. Br J Haematol 2006; 133: 188-197
34. Kalb R, Duerr M, Wagner M, Herterich S, Gross M, Digweed M, Joenje H, Hoehn H, Schindler D. Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat Res 2004; 161: 318-325
35. Kapelushnik J, Or R, Slavin S, Nagler A. A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant 1997; 20: 1109-1110
36. Kohli-Kumar M, Morris C, DeLaat C, Sambrano J, Masterson M, Mueller R, Shahidi NT, Yanik G, Desantes K, Friedman DJ, Auerbach AD, Harris RE. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994; 84: 2050-2054
37. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H, Auerbach AD. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101: 1249-1256
38. Levitus M, Waisfisz Q, Godthelp BC, Vries YD, Hussain S, Wiegant WW, Elghalbzouri-Maghrani E, Steltenpool J, Rooimans MA, Pals G, Arwert F, Mathew CG, Zdzienicka MZ, Hiom K, Winter JP De, Joenje H. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 2005; 37: 934-935
39. Levran O, Attwooll C, Henry RT, Milton KL, Neveling K, Rio P, Batish SD, Kalb R, Velleuer E, Barral S, Ott J, Petrini J, Schindler D, Hanenberg H, Auerbach AD. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 2005; 37: 931-933
40. Lo Ten Foe JR, Kwee ML, Rooimans MA, Oostra AB, Veerman AJ, Weel M van, Pauli RM, Shahidi NT, Dokal I, Roberts I, Altay C, Gluckman E, Gibson RA, Mathew CG, Arwert F, Joenje H. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 1997; 5: 137-148
41. MacMillan ML, Auerbach AD, Davies SM, Defor TE, Gillio A, Giller R, Harris R, Cairo M, Dusenbery K, Hirsch B, Ramsay NK, Weisdorf DJ, Wagner JE. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol 2000; 109: 121-129
42. Niedernhofer LJ, Lalai AS, Hoeijmakers JH. Fanconi Anemia (Cross)linked to DNA Repair. Cell 2005; 123: 1191-1198
43. Patel KJ, Joenje H. Fanconi anemia and DNA replication repair. DNA Repair (Amst) 2007; 6: 885-890
44. Pichierri P, Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. Embo J 2004; 23: 1178-1187
45. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia sub-type FA-N and predispose to childhood cancer. Nat Genet 2007; 39: 162-164
46. Rosenberg PS, Alter BP, Socie G, Gluckman E. Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies. Biol Blood Marrow Transplant 2005; 11: 672-679
47. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005; 105: 67-73
48. Schindler D, Friedl R, Gavvovidis I, Kalb R, Neveling K, Linka Y, Hanenberg H, Kubbies M, Hoehn H. Application of cell cycle testing in Fanconi anemia. In: Schindler D, Hoehn H (Eds). Fanconi anemia A paradigmatic disease for the understanding of cancer and aging. Basel: Karger 2007; 110-130
49. Seyschab H, Friedl R, Sun Y, Schindler D, Hoehn H, Hentze S, Schroeder-Kurth T. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood 1995; 85: 2233-2237
50. Si Y, Ciccone S, Yang FC, Yuan J, Zeng D, Chen S, Vrugt H van de, Critser J, Arwert F, Haneline LS, Clapp DW. Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice. Blood 2006; 108: 4283-4287
51. Sims AE, Spiteri E, Sims 3rd RJ, Arita AG, Lach FP, Landers T, Wurm M, Freund M, Neveling K, Hanenberg H, Auerbach AD, Huang TT. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat Struct Mol Biol 2007; 14: 564-567
52. Socie G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H, Parquet N, Maarek O, Noguera MH, Richard P, Brison O, Gluckman E. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998; 103: 249-255
53. Socie G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277-279
54. Tan PL, Wagner JE, Auerbach AD, Defor TE, Slungaard A, Macmillan ML. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 2006; 46: 630-636
55. Velazquez I, Alter BP. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004; 77: 257-267
56. Wagner JE, Eapen M, Macmillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256-2262
57. Wawer A, Laws HJ, Dilloo D, Göbel U, Burdach S. Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD. Klin Padiatr 2004; 216: 169-175
58. Witherspoon RP, Storb R, Pepe M, Longton G, Sullivan KM. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone. Blood 1992; 79: 289-291
59. Zanis-Neto J, Flowers ME, Medeiros CR, Bitencourt MA, Bonfim CM, Setubal DC, Funke V, Sanders J, Deeg HJ, Kiem HP, Martin P, Leisenring W, Storb R, Pasquini R. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Br J Haematol 2005; 130: 99-106